News & Events
Jefferson Named One of Three New Centers of Excellence in Parkinson’s Care
Jefferson will become one of 48 centers in the world focused on Parkinson’s patient care, research, outreach and education, named by the Parkinson’s Foundation.
Powering Down in an Inherited form of Parkinson’s
New research establishes link between mitochondria dysfunction and dopamine in PINK1 model of disease
Genetic Mutations Link Common Liver Disease and Rare Skin Condition
Jefferson researchers unveil first demonstration of heritable mutations behind non-alcoholic fatty liver disease
Molecule Reduces Accumulation Of Toxic Protein In Parkinson’s Disease Model
The discovery supports GM1 ganglioside as a potential target for Parkinson's therapy.
A Better Avenue for Neurosurgery to Improve Outcomes
Changing the route of entry for minimally invasive neurosurgery provides better outcomes for a wide range of interventions, and is preferred by patients.
Shaky Scaffold Changes Lung Infrastructure
Researchers identify changes in enzymes that may contribute to lung damage in rare genetic disorder
Antioxidant Precursor Molecule Could Improve Parkinson’s
The naturally occurring molecule N-acetylcysteine (NAC) shows benefit in a clinical trial for Parkinson’s Disease
Are Doctors Treating More Thyroid Cancer Patients Than Necessary?
New research may help change treatment practices for patients diagnosed with low risk thyroid cancer.
Grant Awarded to Study Cause of Cerebral Palsy, Chronic Lung Disease, and Developmental Delays in Infants
Researchers aim to study how infections of the fetal membranes during pregnancy can increase risks for a number of serious newborn diseases.